Medical Disorders
Resources
Basic InformationLookupsLatest News
What Was More Deadly for New Yorkers – COVID-19 or the 1918 Flu?U.S. Coronavirus Death Tally Hits New High for SummerPfizer's COVID Vaccine Shows 'Robust' Results in Early TrialFrequent COVID Tests Key to College Reopening: ExpertsMany Community Outbreaks of COVID Traced to Restaurants, BarsPut the Brakes on Driving After a ConcussionStrict, Costly Measures Needed to Reopen Schools: StudyCOVID-19 Risk Up to 7 Times Higher for Young VapersAnother COVID Hazard: False InformationHospitals Full, Doctors Treated Her Severe COVID-19 at HomeFDA Approves First Oral Drug for Spinal Muscular AtrophyCOVID-19 Fears Stop Americans From Seeking Help for Heart EmergenciesAHA News: What Do Heart Patients Need to Know About COVID-19 Now?Have Diabetes? Don't Lose Sight of Danger to Your EyesBlood Test Might Spot Most Dangerous COVID-19 CasesAs Schools Reopen, Report Shows 97,000 U.S. Kids Infected With COVID in Late JulyWhat Parents Need to Know About Teens and ConcussionsBaby's Meningitis Case Highlights Growing Danger of Antibiotic ResistanceAs in Adults, Minority Kids Hit Hardest by COVID-19Simple Test Shows Which Face Masks Are BestBeware of Hand Sanitizers Containing MethanolWhat Athletes Should Know About COVID-19, Heart Damage and Working OutCOVID-19 Causing More Stress in America Than Other Nations: SurveyWill Your Kid Play School Sports This Fall? Here's Some Guidance on Doing It SafelyScientists Call for Broader Use of Faster COVID TestsPeople Are Dying, Going Blind After Drinking Hand Sanitizer, CDC WarnsMore Social Media Use, More Fake COVID NewsSkip the 'Maskne,' Not the MaskObesity Ups Odds for Severe COVID-19, But Age MattersSeven States Join Pact to Speed Coronavirus TestingStudy Casts Doubt on Value of Cholesterol DrugsCOVID-19 Fears Had Sick, Injured Americans Avoiding ERsCancer Diagnoses Plunge as Americans Avoid Screening During PandemicMysterious Paralyzing Illness in Kids Is Set to Return, CDC WarnsMany Older Americans Staying Strong in the PandemicCoronavirus Cases Now Climbing in the MidwestCould the First Drug That Slows Arthritis Be Here?Schools Can Reopen Safely If Precautions in Place, Australian Study ShowsFace Masks, Yes, But Don't Forget Hand-Washing TooEven With PPE, Risk of COVID-19 Still High for Frontline WorkersCoronavirus Pandemic Becoming Far More Widespread, Birx SaysGuard Against Lyme Disease This SummerKids 'Efficient' Transmitters as COVID-19 Raced Through a Georgia Summer CampCollege Students Will Need COVID Tests Every 2-3 Days for Campus Safety: StudyAHA News: Sustained High Blood Pressure May Damage Brain VesselsAnother Side Effect of COVID-19 -- Lasting Hearing Problems?Pandemic Could Complicate Hurricane SeasonStudy Reveals How Coronavirus Travels IndoorsNew Study Sheds Doubt on Notion Kids Aren't COVID-19 SpreadersAHA News: Are Virtual Doctor Visits Safe for Discharged Heart Failure Patients?
Questions and AnswersVideosLinksBook Reviews
Related Topics

Cancer
Men's Health
Women's Health

AHA News: New Test May Predict Who Develops Certain Type of Heart Failure


HealthDay News
Updated: Jul 28th 2020

new article illustration

TUESDAY, July 28, 2020 (American Heart Association News) -- People with higher levels of a specific inflammatory marker may have a greater risk of developing a form of heart failure, according to new research that could help predict who might develop the disease.

The biomarker, called GlycA, is an indicator of inflammation throughout the body. Inflammation is thought to play a pivotal role in heart failure, a chronic condition when the heart muscle doesn't pump as well as it should. It affects an estimated 6.2 million U.S. adults.

The new study, published Tuesday in the American Heart Association journal Circulation: Heart Failure, sought to find out if high levels of GlycA in the blood might predict two subsets of heart failure: heart failure that occurs despite having a preserved – or normal – ejection fraction, and heart failure that occurs with a reduced ejection fraction. Ejection fraction refers to how much blood the left ventricle pumps out into the body.

Researchers studied about 14 years' worth of data from 6,507 middle-age and older people who did not have cardiovascular disease or heart failure at the start of the study. After accounting for various factors – including high blood pressure and diabetes – researchers discovered people with the highest levels of GlycA had more than double the risk of developing heart failure with preserved ejection fraction compared to those with the lowest levels. However, having higher biomarker levels did not impact the risk of developing the other subtype – heart failure with reduced ejection fraction.

Preserved ejection fraction is when the heart contracts normally but the left ventricle doesn't relax properly. Reduced ejection fraction is when the heart muscle does not contract effectively.

"They're really two different entities, so one (treatment) approach doesn't fit all," said Dr. Erin Michos, the study's senior author.

The study's findings are particularly important, she said, because treating preserved ejection fraction is more difficult than treating reduced ejection fraction.

"We don't really have any good therapies for heart failure with preserved ejection fraction," said Michos, associate director of preventive cardiology at the Johns Hopkins Ciccarone Center for the Prevention of Heart Disease in Baltimore. "The best intervention is trying to prevent it from happening in the first place through maintaining a normal weight, exercising, eating a healthy diet and controlling blood pressure and blood glucose."

Since the study was observational, "we can't show that the inflammation actually directly caused the heart failure," she said. "Maybe having much inflammation in the body is just a marker of someone who's sicker in general."

Still, Michos said she'd like to see GlycA testing become more routine. She also called for future research to delve into whether heart failure can be prevented by lowering GlycA levels.

Dr. Ferhaan Ahmad, who was not involved in the research, called it a "novel" study that offers a new way to predict who might develop heart failure with preserved ejection fraction.

"It's a perplexing disorder about which not much is understood. The contractile function of the heart appears to be normal, and yet patients still have pretty severe heart failure symptoms," said Ahmad, director of the Cardiovascular Genetics Program at the University of Iowa in Iowa City.

Figuring out what causes heart failure with preserved ejection fraction will be extremely challenging, he said. But at least the new study gives doctors something to work with.

"The big takeaway is that this may be a superior method to identify patients at higher risk of this pretty intractable disease," Ahmad said. "And then we can intervene early to reduce the risk factors we know already – obesity, diabetes, hypertension. If we can target those, we can reduce the future risk of developing the disease."




Facebook

Amazon Smile

 

Children and Adult services are available now with no wait time.  

Please contact HBH at 860-548-0101, option 2.

 


powered by centersite dot net